Conference
Veligrotug (VRDN-001), a Full Antagonist Monoclonal Antibody to IGF-1 Receptor, in Active Thyroid Eye Disease (TED): THRIVE Phase 3 Efficacy and Safety Topline Results
Authors
Turbin R; Leibowitz S; Yen MT; Mudumbai RC; Cockerham K; Abrams J; Nijhawan N; Zhang-Nunes S; Kossler A; Michalsky C
Volume
66
Publisher
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Publication Date
June 1, 2025
Conference proceedings
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
Issue
8
ISSN
0146-0404